ST. LOUIS – September 3, 2014 – BioGenerator, an entrepreneurial support and investment organization, and venture capital firm Cultivation Capital announce the funding of Immunophotonics, an international biotech company redefining advanced cancer.
BioSTL announced its investment arm, BioGenerator, has provided capital from its Concept Fund to a second woman-led business – EDIS Solutions, a healthcare IT startup focused on integrating pharmaceutical.
Two organizations focused on building and growing the startup community in St. Louis have come together at the intersection of IT and biosciences. ITEN, a 501(c)3 organization that provides a.
In December, The BioGenerator has been recognized as a Center of Best Practice in the second annual “Signs of Competitiveness in the America’s” report from the Inter-American Competitiveness Network under.
19 c
24 c
21 c
18 c
22 c
